Delivery Order SPE2DB22D1052-SPE2DB25FU8QU
Award Date
2/28/25
Potential Completion Date
3/21/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,971.12 firm fixed-price delivery order is for the supply of 200-unit vials of BOTOX medication. The contract has a completion date of November 8, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,299.64 firm fixed-price delivery order is for the supply of 200-unit vials of BOTOX, a popular medication used for various medical and cosmetic applications. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,460.20 firm-fixed-price delivery order is for the supply of 100-unit vials of Botox, with a completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $13,971.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200-unit vials of Botox. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,311.84 firm fixed-price delivery order is for the supply of 100-unit vials of BOTOX, a specialty medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a $5,821.30 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,095.80, is a delivery order for 4,567,094,075 units of BOTOX 200 unit vials. It is a firm fixed-price contract with a completion date of February 20, 2025. The contract was not designated with a specific set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation that serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies. The award is a firm fixed price delivery order for 4,563,856,643 units of BOTOX 200 with a potential value of $3,492.78 and a performance period through March 22, 2024. This award is not associated with any set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,514.96, is a delivery order for 4,567,034,775 units of BOTOX 200 unit vials. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of February 13, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $7,693.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 200 unit vials of BOTOX, a therapeutic medication, with a period of performance through February 4, 2025. The award is not associated with a set-aside program and is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...